Bibliography
Export 12 results:
Filters: Keyword is Immunosuppressive Agents / *therapeutic use [Clear All Filters]
Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc. 2006;38(2):358-61.
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc. 2005;37(2):798-9.
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
The role of immunosuppression in lymphoma. Recent Results Cancer Res. 2002;159:55-66.
Transplantation without steroids. Transplant Proc. 2002;34(6):2076-8.
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplant Proc. 1999;31(7A):84S-85S.
Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc. 1996;28(2):876-8.
Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis. 1989;14(5 Suppl 2):14-8.
Pulmonary surgery in immunosuppressed patients. J Thorac Cardiovasc Surg. 1970;59(6):882-7.
Transplanted carcinoma in an immunosuppressed patient. Transplantation. 1970;9(1):71-4.